QDEL
QUIDELORTHO (QDEL)
NASDAQ
$11.90-$0.47 (-3.80%)
Price as of Jun 23, 2026 6:50 PM EDT
  • $843.5M
    Market Cap
  • -55.26%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/28/2025
12/29/2024
12/31/2023
Income Statement
Total Operating Revenue
2.7B
-1.89%
2.8B
-7.17%
3.0B
N/A
Cost of Revenue
1.5B
-2.70%
1.5B
-0.47%
1.5B
N/A
Gross Profit
30.9M
+4.75%
29.5M
+58.60%
18.6M
N/A
Sales and Marketing Expense
746.3M
-2.67%
766.8M
+0.47%
763.2M
N/A
Research and Development Expense
-186.2M
-14.86%
-218.7M
-11.39%
-246.8M
N/A
Depreciation and Amortization Expense
442.0M
-2.51%
453.4M
-0.83%
457.2M
N/A
Total Operating Expenses
844.0M
+3.10%
818.6M
+3.58%
790.3M
N/A
Operating Profit
-919.2M
-53.12%
-2.0B
-1,509.71%
139.1M
N/A
Interest Income
2.2M
-15.38%
2.6M
-52.73%
5.5M
N/A
Interest Expense
-177.6M
+8.62%
-163.5M
+10.77%
-147.6M
N/A
Interest Income and Expense and Net
-175.4M
+9.01%
-160.9M
+13.23%
-142.1M
N/A
Total Nonoperating Income and Expense
-5.8M
-18.31%
-7.1M
-65.53%
-20.6M
N/A
Income before Taxes
-1.1B
-48.03%
-2.1B
+7,224.74%
-29.1M
N/A
Income Taxes
24.1M
+130.31%
-79.5M
+318.42%
-19.0M
N/A
Extraordinary Items
400,000
N/A
N/A
N/A
N/A
N/A
Net Income
-1.1B
-44.84%
-2.1B
+20,216.83%
-10.1M
N/A
Net Income from Continuing Operations Applicable to Common
-1.1B
-48.03%
-2.1B
+7,224.74%
-29.1M
N/A
Basic EPS and Net Income
-16.69
-45.35%
-30.54
+20,260.00%
-0.15
N/A
Diluted EPS and Net Income
-16.69
-45.35%
-30.54
+20,260.00%
-0.15
N/A
Basic Weighted Average Shares
67.8M
+0.89%
67.2M
+0.60%
66.8M
N/A
Diluted Weighted Average Shares
67.8M
+0.89%
67.2M
+0.60%
66.8M
N/A
Balance Sheet
Cash and Cash Equivalents
169.8M
+72.74%
98.3M
-17.33%
118.9M
N/A
Short-Term Investments
N/A
N/A
0
-100.00%
48.4M
N/A
Cash and Cash Equivalents and Short-Term Investments
169.8M
+72.74%
98.3M
-41.24%
167.3M
N/A
Total Current Assets
1.4B
+18.74%
1.2B
-6.99%
1.3B
N/A
Accumulated Depreciation
944.8M
+30.10%
726.2M
+39.49%
520.6M
N/A
Property and Plant and Equipment and Net
1.4B
-1.59%
1.4B
-4.41%
1.4B
N/A
Total Long-Term Assets
244.4M
-9.72%
270.7M
+50.72%
179.6M
N/A
Total Assets
5.8B
-10.19%
6.4B
-24.99%
8.6B
N/A
Income Taxes Payable
101.5M
+23.93%
81.9M
-59.71%
203.3M
N/A
Total Short-Term Debt
178.3M
-47.83%
341.8M
+144.49%
139.8M
N/A
Total Current Liabilities
966.1M
-3.27%
998.8M
+19.79%
833.8M
N/A
Total Long-Term Debt
2.5B
+15.44%
2.1B
-5.87%
2.3B
N/A
Total Long-Term Liabilities
166.4M
+200.90%
55.3M
-33.85%
83.6M
N/A
Total Liabilities
3.8B
+11.91%
3.4B
-3.32%
3.6B
N/A
Retained Earnings
-996.0M
-833.43%
135.8M
-93.79%
2.2B
N/A
Total Stockholders Equity
1.9B
-35.65%
3.0B
-40.38%
5.0B
N/A
Total Shares Outstanding
67.9M
+0.89%
67.3M
+0.90%
66.7M
N/A
Cash Flow
Cash from Operating Activities
105.2M
+26.75%
83.0M
-70.38%
280.2M
N/A
Capital Expenditures
188.2M
-3.54%
195.1M
-6.78%
209.3M
N/A
Cash from Investing Activities
-192.7M
+28.55%
-149.9M
-20.10%
-187.6M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
155.8M
+219.26%
48.8M
+118.36%
-265.8M
N/A
Financials Ratio
Gross Margin
46.67%
+0.96%
46.23%
N/A
N/A
N/A
Operating Margin
-33.67%
-52.22%
-70.46%
N/A
N/A
N/A
Return on Assets
-18.56%
-32.21%
-27.38%
N/A
N/A
N/A
Return on Equity
-46.15%
-10.15%
-51.36%
N/A
N/A
N/A
Revenue Growth
-1.89%
-73.58%
-7.17%
N/A
N/A
N/A
Current Ratio
1.50
+22.75%
1.22
N/A
N/A
N/A
Cash Ratio
0.18
+78.66%
0.10
N/A
N/A
N/A
Debt-to-Equity Ratio
1.38
+65.87%
0.83
N/A
N/A
N/A
Debt-to-Assets Ratio
0.46
+18.83%
0.39
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow